Trial Profile
A study evaluating the impact of Eslicarbazepine Acetate on serum lipid profile of epilepsy patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- 25 Feb 2016 New trial record